CORRECTION article

Front. Immunol.

Sec. Immunological Memory

Correction: Long non-coding RNAs in response to Ebola virusvaccine-induced immunity

  • 1. Department of Biochemistry and Immunology, Institute of bIological Sciences, Federal University of Minas Gerais, Belo Horizonte, Brazil

  • 2. Department of Clinical and Toxicological Analyses, School of Pharmaceutical Sciences, Universidade de São Paulo,, São Paulo, Brazil

  • 3. Bios-Therapy Physiological Systems for Health SpA, Sansepolcro, Italy

  • 4. Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, United Kingdom

  • 5. aboratory of Genetics and Molecular Cardiology (LGCM), InCor/Clinical Hospital FMUSP (HCMUSP), São Paulo, Brazil

  • 6. Centre of Omics Technologies (CTO), School of Pharmaceutical Sciences, University of São Paulo,, São Paulo, Brazil

  • 7. Strategic Alliances at Merck Research Laboratories, Boston, United States

  • 8. Department of Medical Biotechnologies, Laboratory of Molecular Microbiology and Biotechnology, University of Siena, SIena, Italy

  • 9. Department of Microbiology & Immunology, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden

  • 10. Vaccine Evaluation Center, BC Children’ s Hospital Research Institute, University of British Columbia, Vancouver,, British Columbia, Canada

  • 11. Center of Vaccinology, Department of Pathology and Immunology, Faculty of Medicine, University of Geneva, Geneva, Switzerland

  • 12. Leiden University Center of Infectious Diseases (LUCID), Leiden, Netherlands

  • 13. Dipartimento di Biotecnologie Mediche, Università di Siena, SIena, Italy

  • 14. Institute for Infection Research and Vaccine Development (IIRVD), University Medical Centre Hamburg-Eppendorf, Hamburg, Germany

  • 15. Department for Clinical Immunology of Infectious Diseases, Bernhard Nocht Institute for Tropical Medicine, Hamburg, Germany

  • 16. German Centre for Infection Research, partner site Hamburg-Lübeck-Borstel- Riems, Hamburg, Germany

  • 17. Department of Pediatrics, Indiana University School of Medicine, Indianapolis, Indianapolis, United States

  • 18. Insper, São Paulo, Brazil

  • 19. Department of Clinical and Toxicological Analyses, School of Pharmaceutical Sciences, Universidade de São Paulo, São Paulo, Brazil

The final, formatted version of the article will be published soon.

Summary

Keywords

Ebola (EBOV), lncRNA, RNA, Systems Biology, Vaccine

Received

11 February 2026

Accepted

19 February 2026

Copyright

© 2026 Mamede, Lüscher Dias, Moscardini, Gonzalez-Dias, Marinho, Marcon, Dominguez Crespo Hirata, Eichberg, Medaglini, Harandi, Siegrist, Ottenhoff, Santoro, Addo, Aquime Gonçalves, Ferreira, Polidoro, Franco, Amaral and Nakaya. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Izabela Mamede

Disclaimer

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Outline

Share article

Article metrics